Equillium (EQ) Short-term Investments (2018 - 2024)
Equillium (EQ) reported Short-term Investments of $4.5 million for Q4 2024, down 74.56% year-over-year from $17.6 million in Q1 2024, and down 56.95% on a QoQ basis from $10.4 million in Q3 2024.
Equillium (EQ) has 7 years of Short-term Investments data on file, last reported at $4.5 million in Q4 2024.
- Quarterly Short-term Investments fell 74.56% year-over-year to $4.5 million in Q4 2024, while the trailing twelve-month figure through Dec 2024 was $4.5 million (down 74.56% YoY) and the FY2024 annual result came in at $4.5 million, down 74.56% from the prior year.
- Short-term Investments declined to $4.5 million in Q4 2024 per EQ's latest filing, from $10.4 million in the prior quarter.
- Across five years, Short-term Investments topped out at $58.2 million in Q4 2020 and bottomed at $4.5 million in Q4 2024.
- The 5-year median for Short-term Investments is $22.5 million (2023), against an average of $26.1 million.
- The widest annual swing landed in 2021, when Short-term Investments soared 96.66%; it then sank 74.56% in 2024.
- Tracing EQ's Short-term Investments over 5 years: stood at $58.2 million in 2020, then slumped by 47.84% to $30.3 million in 2021, then sank by 60.73% to $11.9 million in 2022, then jumped by 48.12% to $17.6 million in 2023, then slumped by 74.56% to $4.5 million in 2024.
- Per Business Quant, the three latest EQ Short-term Investments figures stand at $4.5 million (Q4 2024), $10.4 million (Q3 2024), and $22.2 million (Q2 2024).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Equillium | 279.21 Mn | 218.82 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 4.49 Mn |
| Sep 30, 2024 | 10.43 Mn |
| Jun 30, 2024 | 22.24 Mn |
| Mar 31, 2024 | 20.72 Mn |
| Dec 31, 2023 | 17.65 Mn |
| Sep 30, 2023 | 11.92 Mn |
| Jun 30, 2023 | 22.75 Mn |
| Mar 31, 2023 | 37.49 Mn |
| Dec 31, 2022 | 11.92 Mn |
| Sep 30, 2022 | 18.79 Mn |
| Jun 30, 2022 | 33.75 Mn |
| Mar 31, 2022 | 42.58 Mn |
| Dec 31, 2021 | 30.35 Mn |
| Sep 30, 2021 | 13.54 Mn |
| Jun 30, 2021 | 24.12 Mn |
| Mar 31, 2021 | 53.22 Mn |
| Dec 31, 2020 | 58.18 Mn |
| Sep 30, 2020 | 41.29 Mn |
| Jun 30, 2020 | 18.52 Mn |
| Mar 31, 2020 | 27.06 Mn |
| Dec 31, 2019 | 39.92 Mn |
| Sep 30, 2019 | 34.58 Mn |
| Jun 30, 2019 | 34.28 Mn |
| Mar 31, 2019 | 40.21 Mn |
| Dec 31, 2018 | 37.41 Mn |